Optimizing second-line therapy for drug-resistant tuberculosis: The additive value of sequencing for multiple resistance loci

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 8, 2011, Pages 3968-3969

  Heysell, Scott K ^a   Houpt, Eric R ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CAPREOMYCIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; LINEZOLID; MOXIFLOXACIN; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ANTIBIOTIC SENSITIVITY; CASE REPORT; COUGHING; DRUG RESISTANT TUBERCULOSIS; FEMALE; GENE MUTATION; HUMAN; LETTER; MULTIDRUG RESISTANT TUBERCULOSIS; MULTILOCUS SEQUENCE TYPING; MYCOBACTERIUM TUBERCULOSIS; PNEUMONIA; PRIORITY JOURNAL; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; MYCOBACTERIUM TUBERCULOSIS;

EID: 79960337776     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00332-11     Document Type: Letter

References (5)

1. Barnard, M., H. Albert, G. Coetzee, R. O'Brien, and M. E. Bosman. 2008. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am. J. Respir. Crit. Care Med. 177:787-792.
2. Boehme, C. C., et al. 2010. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 363:1005-1015.
3. Campbell, P. J., et al. 2011. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 55:2032-2041.
4. Shah, N. S., et al. 2011. Increasing drug resistance in extensively drug-resistant tuberculosis, South Africa. Emerg. Infect. Dis. 17:510-513.
5. Van Deun, A., A. Martin, and J. C. Palomino. 2010. Diagnosis of drug-resistant tuberculosis: reliability and rapidity of detection. Int. J. Tuberc. Lung Dis. 14:131-140.